首页 > 最新文献

JACC. Cardiovascular interventions最新文献

英文 中文
Atherectomy Is Not Associated With Improved Limb-Based Outcomes Among Patients in the BEST-CLI Trial Undergoing Endovascular Revascularization 在BEST-CLI试验中接受血管内重建术的患者中,动脉粥样硬化切除术与改善肢体预后无关
IF 11.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-12 DOI: 10.1016/j.jcin.2025.10.065
Caitlin W. Hicks MD, MS , Alik Farber MD, MBA , Gheorghe Doros PhD, MBA , Scott Kinlay MBBS, PhD , Richard J. Powell MD , Michael B. Strong MA , Kenneth Rosenfield MD, MSc , Hanaa Aridi MD , Raghu Motaganahalli MD , Andrew Barleben MD , Jeffrey J. Siracuse MD , Ezana Azene MD , Mahmoud Malas MD , Michael S. Conte MD , Mohamed Zayed MD, PhD, MBA , Matthew T. Menard MD

Background

There are substantial data supporting the use of atherectomy for the treatment of coronary artery disease, but data regarding its efficacy for treating chronic limb-threatening ischemia (CLTI) are less robust.

Objectives

The authors aimed to evaluate the association of atherectomy with limb-based outcomes among patients managed with endovascular revascularization in the BEST-CLI (Best Endovascular vs Best Surgical Therapy in Patients With CLTI; NCT02060630) trial.

Methods

BEST-CLI was a prospective randomized trial comparing open and endovascular revascularization strategies for patients with CLTI. We included all patients treated with endovascular revascularization and stratified them according to whether they were treated with or without atherectomy. We evaluated whether atherectomy was associated with major adverse limb events (MALE) (including major reintervention or above-ankle amputation in the index limb) and secondary outcomes using Kaplan-Meier analyses and Cox proportional hazards models.

Results

923 patients underwent an endovascular intervention in the BEST-CLI trial (mean age 67.3 ± 10.0 years, 71.1%[656/923] male, 72.3%[662/916] White race), of which 132 (14.3%) received an atherectomy. After risk adjustment, MALE (adjusted HR [aHR]: 1.30; 95% CI: 0.92-1.84), major reintervention (aHR: 1.07; 95% CI: 0.67-1.73), above-ankle amputation (aHR: 1.32; 95% CI: 0.81-2.15), and all-cause death (aHR: 1.06; 95% CI: 0.75-1.49) were similar for patients who were treated with and without atherectomy. In a sensitivity analysis limited to patients with technical success, atherectomy was associated with higher MALE (unadjusted log-rank P = 0.02; aHR: 1.51; 95% CI: 1.03-2.22).

Conclusions

Atherectomy was associated with similar or slightly worse limb-based outcomes among patients undergoing endovascular revascularization for CLTI compared with other available endovascular technologies.
背景:有大量数据支持动脉粥样硬化切除术用于治疗冠状动脉疾病,但关于其治疗慢性肢体威胁缺血(CLTI)的疗效的数据不太可靠。目的:在Best - cli(最佳血管内治疗vs最佳手术治疗CLTI患者;NCT02060630)试验中,作者旨在评估动脉粥样硬化切除术与血管内血管重建术患者肢体预后的关系。方法best - cli是一项前瞻性随机试验,比较开放和血管内重建术对CLTI患者的治疗效果。我们纳入了所有接受血管内血管重建术治疗的患者,并根据他们是否接受了动脉粥样硬化切除术进行了分层。我们使用Kaplan-Meier分析和Cox比例风险模型评估了动脉粥样硬化切除术是否与主要肢体不良事件(MALE)(包括主要再干预或食指脚踝以上截肢)和次要结局相关。结果923例患者接受了血管内介入治疗(平均年龄67.3±10.0岁,71.1%[656/923]男性,72.3%[662/916]白人),其中132例(14.3%)接受了动脉粥样硬化切除术。风险调整后,男性(校正HR [aHR]: 1.30; 95% CI: 0.92-1.84)、主要再干预(aHR: 1.07; 95% CI: 0.67-1.73)、踝上截肢(aHR: 1.32; 95% CI: 0.81-2.15)和全因死亡(aHR: 1.06; 95% CI: 0.75-1.49)在接受和未接受动脉粥样硬化切除术的患者中相似。在一项仅限于技术成功患者的敏感性分析中,动脉粥样硬化切除术与较高的MALE相关(未校正log-rank P = 0.02; aHR: 1.51; 95% CI: 1.03-2.22)。结论与其他可用的血管内技术相比,接受血管内重建术治疗CLTI患者的下肢预后相似或稍差。
{"title":"Atherectomy Is Not Associated With Improved Limb-Based Outcomes Among Patients in the BEST-CLI Trial Undergoing Endovascular Revascularization","authors":"Caitlin W. Hicks MD, MS ,&nbsp;Alik Farber MD, MBA ,&nbsp;Gheorghe Doros PhD, MBA ,&nbsp;Scott Kinlay MBBS, PhD ,&nbsp;Richard J. Powell MD ,&nbsp;Michael B. Strong MA ,&nbsp;Kenneth Rosenfield MD, MSc ,&nbsp;Hanaa Aridi MD ,&nbsp;Raghu Motaganahalli MD ,&nbsp;Andrew Barleben MD ,&nbsp;Jeffrey J. Siracuse MD ,&nbsp;Ezana Azene MD ,&nbsp;Mahmoud Malas MD ,&nbsp;Michael S. Conte MD ,&nbsp;Mohamed Zayed MD, PhD, MBA ,&nbsp;Matthew T. Menard MD","doi":"10.1016/j.jcin.2025.10.065","DOIUrl":"10.1016/j.jcin.2025.10.065","url":null,"abstract":"<div><h3>Background</h3><div>There are substantial data supporting the use of atherectomy for the treatment of coronary artery disease, but data regarding its efficacy for treating chronic limb-threatening ischemia (CLTI) are less robust.</div></div><div><h3>Objectives</h3><div>The authors aimed to evaluate the association of atherectomy with limb-based outcomes among patients managed with endovascular revascularization in the BEST-CLI (Best Endovascular vs Best Surgical Therapy in Patients With CLTI; <span><span>NCT02060630</span><svg><path></path></svg></span>) trial.</div></div><div><h3>Methods</h3><div>BEST-CLI was a prospective randomized trial comparing open and endovascular revascularization strategies for patients with CLTI. We included all patients treated with endovascular revascularization and stratified them according to whether they were treated with or without atherectomy. We evaluated whether atherectomy was associated with major adverse limb events (MALE) (including major reintervention or above-ankle amputation in the index limb) and secondary outcomes using Kaplan-Meier analyses and Cox proportional hazards models.</div></div><div><h3>Results</h3><div>923 patients underwent an endovascular intervention in the BEST-CLI trial (mean age 67.3 ± 10.0 years, 71.1%[656/923] male, 72.3%[662/916] White race), of which 132 (14.3%) received an atherectomy. After risk adjustment, MALE (adjusted HR [aHR]: 1.30; 95% CI: 0.92-1.84), major reintervention (aHR: 1.07; 95% CI: 0.67-1.73), above-ankle amputation (aHR: 1.32; 95% CI: 0.81-2.15), and all-cause death (aHR: 1.06; 95% CI: 0.75-1.49) were similar for patients who were treated with and without atherectomy. In a sensitivity analysis limited to patients with technical success, atherectomy was associated with higher MALE (unadjusted log-rank <em>P =</em> 0.02; aHR: 1.51; 95% CI: 1.03-2.22).</div></div><div><h3>Conclusions</h3><div>Atherectomy was associated with similar or slightly worse limb-based outcomes among patients undergoing endovascular revascularization for CLTI compared with other available endovascular technologies.</div></div>","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"19 1","pages":"Pages 96-107"},"PeriodicalIF":11.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Full Issue PDF 完整版PDF
IF 11.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-12 DOI: 10.1016/S1936-8798(25)03221-2
{"title":"Full Issue PDF","authors":"","doi":"10.1016/S1936-8798(25)03221-2","DOIUrl":"10.1016/S1936-8798(25)03221-2","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"19 1","pages":"Pages I-CXLVII"},"PeriodicalIF":11.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PRODIGY Reclassification May Alter the Meta-Analytical Results on Aspirin vs P2Y12 Inhibitor Monotherapy After Short DAPT PRODIGY重新分类可能会改变短期DAPT后阿司匹林与P2Y12抑制剂单药治疗的meta分析结果
IF 11.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-12 DOI: 10.1016/j.jcin.2025.09.051
Grzegorz Procyk MD , Kamil Tkacz
{"title":"PRODIGY Reclassification May Alter the Meta-Analytical Results on Aspirin vs P2Y12 Inhibitor Monotherapy After Short DAPT","authors":"Grzegorz Procyk MD ,&nbsp;Kamil Tkacz","doi":"10.1016/j.jcin.2025.09.051","DOIUrl":"10.1016/j.jcin.2025.09.051","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"19 1","pages":"Page 137"},"PeriodicalIF":11.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Implant in Patients Weighing ≤30 kg 体重≤30kg患者经导管肺动脉瓣置入术后的远期疗效
IF 11.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-12 DOI: 10.1016/j.jcin.2025.10.049
Elisa K. McCarthy MD , Stanimir Georgiev MD , Yulin Zhang PhD , Matthew E. Boucek MD , Kirby C. Johnson , Ayush Jaggi MPH , Daniel S. Levi MD , Lynn F. Peng MD , Mary Hunt Martin MD , Brian H. Morray MD , Athar M. Qureshi MD , Alejandro J. Torres MD , Allison K. Cabalka MD , Holly Bauser-Heaton MD, PhD , Felix Berger MD , Peter Ewert MD , Doff B. McElhinney MD

Background

Small multicenter studies have shown that transcatheter pulmonary valve replacement (TPVR) can be performed with good procedural and early hemodynamic results in patients weighing <30 kg; little is known about longer term outcomes.

Objectives

The aim of this study was to characterize long-term outcomes after Melody valve placement in patients weighing ≤30 kg.

Methods

Selected centers participating in prior registry studies provided updated outcome data.

Results

Between April 2009 and April 2019, 199 patients weighing ≤30kg underwent successful Melody valve placement across 10 centers. During a median follow-up period of nearly 8 years, 78 patients underwent initial reintervention with balloon dilation (n = 20), transcatheter valve-in-valve (n = 30), or explantation (n = 28). Among patients who had not undergone reintervention, 81% of those with available echocardiograms had good valve function. Thirty-two patients developed endocarditis, 20 with predisposing factors; 9 were managed medically. Estimated freedom from pulmonary valve reintervention at 10 years was 46% (95% CI: 36%-55%). On age- and weight-adjusted multivariable Cox regression, right ventricular systolic pressure immediately after implantation (HR: 1.03; 95% CI: 1.00-1.05; P = 0.026) was associated with freedom from reintervention. Freedom from Melody valve explantation at 10 years was 78% (95% CI: 69%-85%), and freedom from endocarditis was 79% (95% CI: 71%-86%). These outcomes did not vary significantly according to weight, delivery system, or era of implantation.

Conclusions

In this large multicenter study, longer term survival and freedom from reintervention or explantation after TPVR were similar to previously reported data for small patients with a surgical pulmonary conduit or bioprosthetic valve. These findings support the utility of TPVR with a Melody valve for delaying surgical valve replacement in small patients.
背景:小型多中心研究表明,在体重30 kg的患者中,经导管肺瓣膜置换术(TPVR)可以获得良好的程序和早期血流动力学结果。人们对长期结果知之甚少。目的本研究的目的是描述体重≤30kg的患者置放Melody瓣膜后的长期预后。方法选择参与先前注册研究的中心提供最新的结果数据。结果2009年4月至2019年4月,199名体重≤30kg的患者在10个中心成功进行了Melody瓣膜置换术。在近8年的中位随访期间,78例患者接受了球囊扩张(n = 20)、经导管瓣内置换术(n = 30)或外植术(n = 28)的初始再干预。在未接受再干预的患者中,超声心动图显示81%的患者瓣膜功能良好。32例发生心内膜炎,20例有易感因素;9人接受医疗处理。估计10年后肺动脉瓣再介入的自由度为46% (95% CI: 36%-55%)。经年龄和体重调整的多变量Cox回归分析,植入后立即右心室收缩压(HR: 1.03; 95% CI: 1.00-1.05; P = 0.026)与再次干预自由相关。10年后梅洛迪瓣膜外植的自由率为78% (95% CI: 69%-85%),心内膜炎的自由率为79% (95% CI: 71%-86%)。这些结果没有因体重、输送系统或植入时间的不同而有显著差异。结论:在这项大型多中心研究中,TPVR术后的长期生存率和再次干预或移植的自由度与先前报道的小患者手术肺导管或生物假瓣膜的数据相似。这些发现支持TPVR与Melody瓣膜在小患者延迟手术瓣膜置换术中的应用。
{"title":"Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Implant in Patients Weighing ≤30 kg","authors":"Elisa K. McCarthy MD ,&nbsp;Stanimir Georgiev MD ,&nbsp;Yulin Zhang PhD ,&nbsp;Matthew E. Boucek MD ,&nbsp;Kirby C. Johnson ,&nbsp;Ayush Jaggi MPH ,&nbsp;Daniel S. Levi MD ,&nbsp;Lynn F. Peng MD ,&nbsp;Mary Hunt Martin MD ,&nbsp;Brian H. Morray MD ,&nbsp;Athar M. Qureshi MD ,&nbsp;Alejandro J. Torres MD ,&nbsp;Allison K. Cabalka MD ,&nbsp;Holly Bauser-Heaton MD, PhD ,&nbsp;Felix Berger MD ,&nbsp;Peter Ewert MD ,&nbsp;Doff B. McElhinney MD","doi":"10.1016/j.jcin.2025.10.049","DOIUrl":"10.1016/j.jcin.2025.10.049","url":null,"abstract":"<div><h3>Background</h3><div>Small multicenter studies have shown that transcatheter pulmonary valve replacement (TPVR) can be performed with good procedural and early hemodynamic results in patients weighing &lt;30 kg; little is known about longer term outcomes.</div></div><div><h3>Objectives</h3><div>The aim of this study was to characterize long-term outcomes after Melody valve placement in patients weighing ≤30 kg.</div></div><div><h3>Methods</h3><div>Selected centers participating in prior registry studies provided updated outcome data.</div></div><div><h3>Results</h3><div>Between April 2009 and April 2019, 199 patients weighing ≤30kg underwent successful Melody valve placement across 10 centers. During a median follow-up period of nearly 8 years, 78 patients underwent initial reintervention with balloon dilation (n = 20), transcatheter valve-in-valve (n = 30), or explantation (n = 28). Among patients who had not undergone reintervention, 81% of those with available echocardiograms had good valve function. Thirty-two patients developed endocarditis, 20 with predisposing factors; 9 were managed medically. Estimated freedom from pulmonary valve reintervention at 10 years was 46% (95% CI: 36%-55%). On age- and weight-adjusted multivariable Cox regression, right ventricular systolic pressure immediately after implantation (HR: 1.03; 95% CI: 1.00-1.05; <em>P</em> = 0.026) was associated with freedom from reintervention. Freedom from Melody valve explantation at 10 years was 78% (95% CI: 69%-85%), and freedom from endocarditis was 79% (95% CI: 71%-86%). These outcomes did not vary significantly according to weight, delivery system, or era of implantation.</div></div><div><h3>Conclusions</h3><div>In this large multicenter study, longer term survival and freedom from reintervention or explantation after TPVR were similar to previously reported data for small patients with a surgical pulmonary conduit or bioprosthetic valve. These findings support the utility of TPVR with a Melody valve for delaying surgical valve replacement in small patients.</div></div>","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"19 1","pages":"Pages 80-92"},"PeriodicalIF":11.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conflict of Interest Among Journal Authors 期刊作者的利益冲突
IF 11.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-12 DOI: 10.1016/j.jcin.2025.10.048
Christopher J. White MD (Associate Editor, JACC: Cardiovascular Interventions)
{"title":"Conflict of Interest Among Journal Authors","authors":"Christopher J. White MD (Associate Editor, JACC: Cardiovascular Interventions)","doi":"10.1016/j.jcin.2025.10.048","DOIUrl":"10.1016/j.jcin.2025.10.048","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"19 1","pages":"Pages 142-143"},"PeriodicalIF":11.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Repeated Drug-Coated Balloon for Restenosis Following Femoropopliteal Drug-Coated Balloon Treatment 反复药物包被球囊治疗股腘动脉再狭窄的影响
IF 11.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-12 DOI: 10.1016/j.jcin.2025.10.043
Yoshimitsu Soga MD, PhD , Mitsuyoshi Takahara MD, PhD , Osamu Iida MD, PhD , Yusuke Tomoi MD , Daizo Kawasaki MD, PhD , Akiko Tanaka MD , Yasutaka Yamauchi MD, PhD , Kazuki Tobita MD , Amane Kozuki MD, PhD , Masahiko Fujihara MD , OYSTER Investigators
{"title":"Impact of Repeated Drug-Coated Balloon for Restenosis Following Femoropopliteal Drug-Coated Balloon Treatment","authors":"Yoshimitsu Soga MD, PhD ,&nbsp;Mitsuyoshi Takahara MD, PhD ,&nbsp;Osamu Iida MD, PhD ,&nbsp;Yusuke Tomoi MD ,&nbsp;Daizo Kawasaki MD, PhD ,&nbsp;Akiko Tanaka MD ,&nbsp;Yasutaka Yamauchi MD, PhD ,&nbsp;Kazuki Tobita MD ,&nbsp;Amane Kozuki MD, PhD ,&nbsp;Masahiko Fujihara MD ,&nbsp;OYSTER Investigators","doi":"10.1016/j.jcin.2025.10.043","DOIUrl":"10.1016/j.jcin.2025.10.043","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"19 1","pages":"Pages 111-114"},"PeriodicalIF":11.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mind the Gap! 小心缝隙!
IF 11.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-12 DOI: 10.1016/j.jcin.2025.10.061
Mara Pilati MD , Fabiola Boccuto MD , Claudia Montanaro MD , Paolo Ciancarella MD , Gianfranco Butera MD
{"title":"Mind the Gap!","authors":"Mara Pilati MD ,&nbsp;Fabiola Boccuto MD ,&nbsp;Claudia Montanaro MD ,&nbsp;Paolo Ciancarella MD ,&nbsp;Gianfranco Butera MD","doi":"10.1016/j.jcin.2025.10.061","DOIUrl":"10.1016/j.jcin.2025.10.061","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"19 1","pages":"Pages 122-124"},"PeriodicalIF":11.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous Papillary Muscle Banding to Reshape Failing Left Ventricle 经皮乳头肌束带重塑衰竭左心室
IF 11.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-12 DOI: 10.1016/j.jcin.2025.10.047
Piotr Musialek MD, DPhil , Lukasz Tekieli MD, PhD , Adam Mazurek MD, PhD , Lukasz Czyz MD , Jakub Chmiel MD , Krzysztof Bartus MD, PhD , R. Pawel Banys MSc (Eng) , Joanna Szachowicz-Jaworska MD , Jacek Piatek MD, PhD , Andrzej Gackowski MD, PhD
{"title":"Percutaneous Papillary Muscle Banding to Reshape Failing Left Ventricle","authors":"Piotr Musialek MD, DPhil ,&nbsp;Lukasz Tekieli MD, PhD ,&nbsp;Adam Mazurek MD, PhD ,&nbsp;Lukasz Czyz MD ,&nbsp;Jakub Chmiel MD ,&nbsp;Krzysztof Bartus MD, PhD ,&nbsp;R. Pawel Banys MSc (Eng) ,&nbsp;Joanna Szachowicz-Jaworska MD ,&nbsp;Jacek Piatek MD, PhD ,&nbsp;Andrzej Gackowski MD, PhD","doi":"10.1016/j.jcin.2025.10.047","DOIUrl":"10.1016/j.jcin.2025.10.047","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"19 1","pages":"Pages 127-133"},"PeriodicalIF":11.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stress Hyperglycemia Should Not Be Confused With Diabetes Mellitus 应激性高血糖不应与糖尿病混淆
IF 11.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-12 DOI: 10.1016/j.jcin.2025.04.052
Hao Yang MM, Jieyi Wang MD, Aisong Zhu MD
{"title":"Stress Hyperglycemia Should Not Be Confused With Diabetes Mellitus","authors":"Hao Yang MM,&nbsp;Jieyi Wang MD,&nbsp;Aisong Zhu MD","doi":"10.1016/j.jcin.2025.04.052","DOIUrl":"10.1016/j.jcin.2025.04.052","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"19 1","pages":"Page 139"},"PeriodicalIF":11.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OCT-Guided Clues OCT-Guided线索
IF 11.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-12 DOI: 10.1016/j.jcin.2025.05.048
Ioannis Skalidis MD, PhD, Thierry Unterseeh MD, Pietro Laforgia MD, Stephane Chapagne MD, Nicolas Amabile MD, PhD
{"title":"OCT-Guided Clues","authors":"Ioannis Skalidis MD, PhD,&nbsp;Thierry Unterseeh MD,&nbsp;Pietro Laforgia MD,&nbsp;Stephane Chapagne MD,&nbsp;Nicolas Amabile MD, PhD","doi":"10.1016/j.jcin.2025.05.048","DOIUrl":"10.1016/j.jcin.2025.05.048","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"19 1","pages":"Page 141"},"PeriodicalIF":11.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145950254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JACC. Cardiovascular interventions
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1